LAZARD INC (LAZ) Stock Analyst Ratings
NYSE:LAZ - New York Stock Exchange, Inc. - US52110M1099 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 71% to LAZ. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 54.93. This target is 4.34% above the current price.
LAZ was analyzed by 14 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about LAZ.
In the previous month the buy percentage consensus was at a similar level.
LAZ was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-03 | UBS | Maintains | Neutral -> Neutral |
| 2025-01-31 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-01-31 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-31 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-15 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-01-14 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-13 | Keefe, Bruyette & Woods | Maintains | Market Perform -> Market Perform |
| 2025-01-03 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2024-12-20 | Keefe, Bruyette & Woods | Downgrade | Outperform -> Market Perform |
| 2024-12-09 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2024-11-01 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2024-11-01 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-10-09 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-10-08 | UBS | Maintains | Neutral -> Neutral |
| 2024-09-23 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-09-12 | Wells Fargo | Initiate | Equal-Weight |
| 2024-07-26 | Keefe, Bruyette & Woods | Reiterate | Outperform -> Outperform |
| 2024-07-26 | Goldman Sachs | Maintains | Sell -> Sell |
| 2024-07-23 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-06-21 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-04-26 | Keefe, Bruyette & Woods | Reiterate | Outperform -> Outperform |
| 2024-04-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-03-26 | UBS | Maintains | Neutral -> Neutral |
| 2024-02-05 | UBS | Maintains | Neutral -> Neutral |
| 2024-01-29 | Keefe, Bruyette & Woods | Reiterate | Outperform |
| 2024-01-09 | UBS | Maintains | Neutral -> Neutral |
| 2024-01-03 | Wolfe Research | Upgrade | Peer Perform -> Outperform |
| 2023-12-19 | Goldman Sachs | Maintains | Sell -> Sell |
| 2023-10-27 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-10-12 | Morgan Stanley | Maintains | Overweight -> Overweight |